Find the Right Market Report
Search thousands of industry reports, market insights, and research studies in one place.
Search thousands of industry reports, market insights, and research studies in one place.
Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
29 December 2025
Announcement Next Gen Diagnostics announced the exciting offshoot of its Infection Prevention division into an independent and strong-headed company from 1st January 2026. The company will be called ...
26 December 2025
Announcement Samsung Biologics, a popular contract development and manufacturing organisation (CDMO), has declared that Samsung Biologics America, a fully owned U.S subsidiary, has signed a definitiv...
26 December 2025
Announcement Ipsen, a French-based biopharmaceutical company concentrating on marketing and drug development in neuroscience, rare disease and oncology spaces, has proudly revealed its exclusive lice...
26 December 2025
Announcement Alvotech, a leading and promising biotechnology company excelling in the manufacture and establishment of biosimilar drugs for patients globally, showed excitement about its new launches...
26 December 2025
Announcement Cytokinetics received a green signal from the FDA for its cardiac myosin inhibitor, which has reserved the biotech to compete with Bristol Myers Squibb in the heart disease sector. This ...
24 December 2025
Announcement Trump has been in the limelight since its tariffs storm that shook the trading, healthcare and other sectors as well. Recently, Trump has come up with some favourable and convincing deal...
24 December 2025
FDA’s Policy Initiatives The FDA’s guidance and various policies were at a pace this year. Neverthless the guidance on vaccines and rare disease have attracted most of the deals, with pol...
24 December 2025
Announcement Tolmar, Inc. has proudly declared that its extended indication for Rubraca® has finally received the U.S. Food and Drug Administration (FDA) stamp. The extended indication allows its...
24 December 2025
Announcement Faron Pharmaceuticals Ltd., a leading clinical-level biopharmaceutical company, has entered a partnership deal to begin with the new investigator-initiated trial (IIT), BLAZE trial in th...
23 December 2025
Announcement Novo Nordisk has now registered a new drug application to receive the FDA’s approval stamp. This decision by Novo stems from its competition with Lilly in the weight loss market so...
Speak with a healthcare analyst about your research, consulting, or platform needs.